Vibro Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 64 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.40 M
- Revenue Growth 9.70%
- Profit Growth -18.74%
- Ebitda -3.53%
- Net Worth 15.45%
- Total Assets 24.69%
About Vibro Pharma
Vibro Pharma Private Limited (VPPL) was founded in India on 01 April 1960 and has a glorious history of 64 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.40 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajendra Shah, Rita Shah, and Vishal Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U99999MH1960PTC011626
- Company No.
011626
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 1960
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vibro Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Shah  | Managing Director | 17-Aug-1966 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rita Shah | Director | 16-May-1994 | Current |
| Vishal Shah | Whole-Time Director | 01-Apr-1996 | Current |
Financial Performance of Vibro Pharma.
Vibro Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.7% increase. The company also saw a substantial fall in profitability, with a 18.74% decrease in profit. The company's net worth Soared by an impressive increase of 15.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vibro Pharma?
Unlock access to Vibro Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Crescent Labs Private LimitedRajendra Shah and Vishal Shah are mutual person
Unisol Estate Private LimitedRajendra Shah and Vishal Shah are mutual person
Charges (Loans)
₹0
₹1.40 M
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.12 Cr
- Union Bak Of Indiaa : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jun 1999 | Union Bank Of India | ₹0.20 M | Satisfied |
| 05 Mar 1999 | Union Bank Of India | ₹0.40 M | Satisfied |
| 05 Mar 1999 | Union Bank Of India | ₹0.28 M | Satisfied |
| 04 Mar 1987 | Union Bank Of India | ₹0.28 M | Satisfied |
| 10 Jan 1980 | Union Bak Of Indiaa | ₹0.05 M | Satisfied |
How Many Employees Work at Vibro Pharma?
Unlock and access historical data on people associated with Vibro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vibro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vibro Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.